Skip to main content

Advertisement

Log in

Type 2 Diabetes Mellitus and Osteoarthritis: the Role of Glucose Transporters

  • Review Paper
  • Published:
Clinical Reviews in Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

Type 2 diabetes mellitus (T2DM) and osteoarthritis (OA) are the most common chronic diseases worldwide. Previous studies indicate the involvement of glucose transporters (GLUTs) in the development of OA induced by diabetes—specifically, the increased glucose level inside the cell and its positive effect on cytokines’ or AGE receptors’ activity. Thus, a study was conducted to investigate whether T2DM increases the chance of developing OA and what role GLUTs play in causing this disease. To identify the research question in this scoping review, a preliminary search was carried out in the PubMed database, looking at studies of T2DM and OA and their association with GLUTs. Searches for articles in English were carried out in the PubMed database. The search components were first evaluated using a MeSH term system. The search terms were divided into three groups: T2DM, OA, and GLUT. After removing duplicates from the original search (n = 3252), 864 studies were retrieved for the screening stage. A total of 104 studies were included in the selection phase, and, in the end, 36 studies were eligible. According to the studies, four themes—T2DM and GLUTs, OA and GLUTs, T2DM and OA, and T2DM and OA and GLUTs—were found to classify the findings. In conclusion, GLUT-1 composition in the plasma membrane of articular cell and chondrocyte increases glucose uptake in hyperglycemic conditions. This event leads to increased levels of inflammatory cytokines—such as IL-1β, TGF-β1, and MMP—oxidative stress, and AGEs. Therefore, these alterations induce the deleterious effects of glucotoxicity at the joint surface, which ultimately leads to OA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence. Acta Diabetol. 2016;53(6):879–89.

    Article  CAS  Google Scholar 

  2. Balkhi B, Alwhaibi M, Alqahtani N, Alhawassi T, Alshammari TM, Mahmoud M, et al. Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia. BMJ Open. 2019;9(7):e029280.

    Article  Google Scholar 

  3. Funck-Brentano T, Nethander M, Movérare-Skrtic S, Richette P, Ohlsson C. Causal factors for knee, hip and hand osteoarthritis: a Mendelian randomization study in the UK Biobank. Arthritis Rheumatol. 2019;71(10):1634–41.

    Article  CAS  Google Scholar 

  4. Skou ST, Pedersen BK, Abbott JH, Patterson B, Barton C. Physical activity and exercise therapy benefit more than just symptoms and impairments in people with hip and knee. Osteoarthritis J Orthop Sports Phys Ther. 2018;48(6):439–47.

    Article  Google Scholar 

  5. Thomas S, Browne H, Mobasheri A, Rayman MP. What is the evidence for a role for diet and nutrition in osteoarthritis? Rheumatology. 2018;57(suppl_4):iv61–74.

    Article  CAS  Google Scholar 

  6. Alenazi AM, Alothman S, Alshehri MM, Rucker J, Waitman LR, Wick J, et al. The prevalence of type 2 diabetes and associated risk factors with generalized osteoarthritis: a retrospective study using ICD codes for clinical data repository system. Clin Rheumatol. 2019:1–9.

  7. Bi J, Cai W, Ma T, Deng A, Ma P, Han Y, et al. Protective effect of vildagliptin on TNF-α-induced chondrocyte senescence. IUBMB Life. 2019.

  8. Yang Y, Wang Y, Kong Y, Zhang X, Zhang H, Gang Y, et al. Carnosine prevents type 2 diabetes-induced osteoarthritis through the ROS/NF-κB pathway. Front Pharmacol. 2018;9:598.

    Article  Google Scholar 

  9. Arellano Perez Vertti RD, Aguilar Muniz LS, Moran Martinez J, Gonzalez Galarza FF, Arguello Astorga R. Cartilage oligomeric matrix protein levels in type 2 diabetes associated with primary knee osteoarthritis patients. Genet Test Mol Biomarkers. 2019;23(1):16–22.

    Article  CAS  Google Scholar 

  10. Adeyemi WJ, Olayaki LA. Additive and nonadditive effects of salmon calcitonin and omega-3 fatty acids on antioxidant, hematological and bone and cartilage markers in experimental diabetic-osteoarthritic rats. Chin J Physiol. 2019;62(3):108.

    Article  CAS  Google Scholar 

  11. Juybari KB, Hosseinzadeh A, Sharifi AM. Protective effects of atorvastatin against high glucose-induced nuclear factor-κB activation in cultured C28I2 chondrocytes. J Recept Signal Transduct. 2019;39(1):1–8.

    Article  CAS  Google Scholar 

  12. DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin. 2004;88(4):787–835.

    CAS  Google Scholar 

  13. Klip A, Marette A, Dimitrakoudis D, Ramlal T, Giacca A, Shi ZQ, et al. Effect of diabetes on glucoregulation: from glucose transporters to glucose metabolism in vivo. Diabetes Care. 1992;15(11):1747–66.

    Article  CAS  Google Scholar 

  14. Veronese N, Cooper C, Reginster J-Y, Hochberg M, Branco J, Bruyère O, et al., editors. Type 2 diabetes mellitus and osteoarthritis. Seminars in arthritis and rheumatism; 2019: Elsevier

  15. Daudt HM, van Mossel C, Scott SJ. Enhancing the scoping study methodology: a large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Med Res Methodol. 2013;13(1):48.

    Article  Google Scholar 

  16. Arksey H, O’Malley L. Scoping studies: towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19–32.

    Article  Google Scholar 

  17. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73.

    Article  Google Scholar 

  18. Wittenauer R, Smith L, Aden K. Background paper 6.12 osteoarthritis. World Health Organisation. 2013.

  19. Majjad A, Errahali Y, Toufik H, Djossou HJ, Ghassem M, Kasouati J, et al. Musculoskeletal disorders in patients with diabetes mellitus: a cross-sectional study. Int J Rheumatol. 2018;2018.

  20. Duclos M. Osteoarthritis, obesity and type 2 diabetes: the weight of waist circumference. Ann Phys Rehabil Med. 2016;59(3):157–60.

    Article  Google Scholar 

  21. Courties A, Sellam J. Osteoarthritis and type 2 diabetes mellitus: what are the links? Diabetes Res Clin Pract. 2016;122:198–206.

    Article  CAS  Google Scholar 

  22. Neumann J, Hofmann FC, Heilmeier U, Ashmeik W, Tang K, Gersing AS, et al. Type 2 diabetes patients have accelerated cartilage matrix degeneration compared to diabetes free controls: data from the osteoarthritis initiative. Osteoarthr Cartil. 2018;26(6):751–61.

    Article  CAS  Google Scholar 

  23. Courties A, Sellam J, Berenbaum F. Metabolic syndrome-associated osteoarthritis. Curr Opin Rheumatol. 2017;29(2):214–22.

    Article  CAS  Google Scholar 

  24. Ribeiro M, de Figueroa PL, Blanco F, Mendes A, Carames B. Insulin decreases autophagy and leads to cartilage degradation. Osteoarthr Cartil. 2016;24(4):731–9.

    Article  CAS  Google Scholar 

  25. Pritchard J, Papaioannou A, Tomowich C, Giangregorio L, Atkinson S, Beattie K, et al. Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone. Bone. 2013;54(1):76–82.

    Article  CAS  Google Scholar 

  26. Chen Y, Huang Y-C, Yan CH, Chiu KY, Wei Q, Zhao J, et al. Abnormal subchondral bone remodeling and its association with articular cartilage degradation in knees of type 2 diabetes patients. Bone Res. 2017;5(1):17034.

    Article  CAS  Google Scholar 

  27. Dubey N, Ningrum D, Dubey R, Deng Y-H, Li Y-C, Wang P, et al. Correlation between diabetes mellitus and knee osteoarthritis: a dry-to-wet lab approach. Int J Mol Sci. 2018;19(10):3021.

    Article  Google Scholar 

  28. Luo S, Shi Q, Chen J, Wang H, Wu W, Zha Z. Expression and significance of MMPs in synovial fluid, serum and PBMC culture supernatant stimulated by LPS in osteoarthritis patients with or without diabetes. Exp Clin Endocrinol Diabetes. 2019;127(04):195–202.

    Article  CAS  Google Scholar 

  29. Barrett KE, Barman SM, Boitano S, Brooks H. Ganong’s review of medical physiology. 23. NY: McGraw-Hill Medical; 2009.

    Google Scholar 

  30. Mobasheri A, Vannucci S, Bondy C, Carter S, Innes J, Arteaga M, et al. Glucose transport and metabolism in chondrocytes: a key to understanding chondrogenesis, skeletal development and cartilage degradation in osteoarthritis. Histol Histopathol. 2002.

  31. Hajiaghaalipour F, Khalilpourfarshbafi M, Arya A. Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus. Int J Biol Sci. 2015;11(5):508–24.

    Article  CAS  Google Scholar 

  32. Rosa SC, Gonçalves J, Judas F, Mobasheri A, Lopes C, Mendes AF. Impaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage. Arthritis Res Ther. 2009;11(3):R80.

    Article  Google Scholar 

  33. Schett G, Kleyer A, Perricone C, Sahinbegovic E, Iagnocco A, Zwerina J, et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013;36(2):403–9.

    Article  Google Scholar 

  34. Rosa S, Rufino A, Judas F, Tenreiro C, Lopes M, Mendes A. Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin. Osteoarthr Cartil. 2011;19(6):719–27.

    Article  CAS  Google Scholar 

  35. Rufino AT, Rosa SC, Judas F, Mobasheri A, Lopes MC, Mendes AF. Expression and function of K (ATP) channels in normal and osteoarthritic human chondrocytes: possible role in glucose sensing. J Cell Biochem. 2013;114(8):1879–89.

    Article  CAS  Google Scholar 

  36. McNulty AL, Stabler TV, Vail TP, McDaniel GE, Kraus VB. Dehydroascorbate transport in human chondrocytes is regulated by hypoxia and is a physiologically relevant source of ascorbic acid in the joint. Arthritis Rheum. 2005;52(9):2676–85.

    Article  CAS  Google Scholar 

  37. Garcia-Carbonell R, Divakaruni AS, Lodi A, Vicente-Suarez I, Saha A, Cheroutre H, et al. Critical role of glucose metabolism in rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheumatol. 2016;68(7):1614–26.

    Article  CAS  Google Scholar 

  38. Laiguillon M-C, Courties A, Houard X, Auclair M, Sautet A, Capeau J, et al. Characterization of diabetic osteoarthritic cartilage and role of high glucose environment on chondrocyte activation: toward pathophysiological delineation of diabetes mellitus-related osteoarthritis. Osteoarthr Cartil. 2015;23(9):1513–22.

    Article  Google Scholar 

  39. Wang C, Silverman RM, Shen J, O’Keefe RJ. Distinct metabolic programs induced by TGF-β1 and BMP2 in human articular chondrocytes with osteoarthritis. J Orthop Transl. 2018;12:66–73.

    Google Scholar 

  40. Yang X, Chen W, Zhao X, Chen L, Li W, Ran J, et al. Pyruvate kinase M2 modulates the glycolysis of chondrocyte and extracellular matrix in osteoarthritis. DNA Cell Biol. 2018;37(3):271–7.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

We would like to thank the vice-chancellor of research affairs of Dezful University of Medical Sciences, Dezful, Iran, for its assistance in the production of this scoping review research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ali Akbar Oroojan.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Appendix

Appendix

Table 3 The characteristics of eligible and remained studies

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ashrafizadeh, H., Ashrafizadeh, M. & Oroojan, A.A. Type 2 Diabetes Mellitus and Osteoarthritis: the Role of Glucose Transporters. Clinic Rev Bone Miner Metab 18, 1–17 (2020). https://doi.org/10.1007/s12018-020-09270-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12018-020-09270-7

Keywords

Navigation